Home
Conditions
Neoplastic Syndromes, Hereditary

Clinical trial condition

Neoplastic Syndromes, Hereditary

Explore clinical trials studying Neoplastic Syndromes, Hereditary. Study availability and eligibility vary by location and protocol.

869 public trials 154 recruiting studies

Refine in advanced search Browse all conditions

Neoplastic Syndromes, Hereditary trial results

Completed

A Study of IMMray™ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk Groups

NCT03693378

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Digestive System Neoplasms, +16 more
Locations: Stanford Gastroenterology and Hepatology Stanford, California, United States

Yale University New Haven, Connecticut, United States

University of Chicago Medical Center Chicago, Illinois, United States

Massachusetts General Hospital Boston, Massachusetts, United States

View all 21 locations

View Trial Details

Completed

Magnetic Resonance Imaging Screening in Li Fraumeni Syndrome

NCT01737255

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA Repair-Deficiency Disorders, Genetic Diseases, Inborn, +5 more
Locations: Cancer Genetics Unit, Royal Marsden Hospital Sutton, Surrey, United Kingdom

View Trial Details

Completed

A Study to Learn How Safe Elinzanetant is, How it Affects the Body, and How it Moves Into, Through and Out of the Body After Single and Multiple Doses in Japanese Healthy Female Adults

NCT04981431

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine Gland Neoplasms, Endocrine System Diseases, +8 more
Locations: SOUSEIKAI Fukuoka Mirai Hospital Fukuoka, Japan

View Trial Details

Completed

Bioavailability of Anthocyanins From Aronia Extract in Healthy Men - a Pilot Study

NCT04645394

Conditions: Bioavailability, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine Gland Neoplasms, +8 more
Locations: Aarhus University Hospital Aarhus N, Danmark, Denmark

View Trial Details

Completed

A Study to Learn How Different Levels of Decreased Liver Function Influence Blood Levels of Elinzanetant Compared to Normal Liver Function in Male and Female Participants

NCT04903821

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine Gland Neoplasms, Endocrine System Diseases, +8 more
Locations: APEX GmbH München, Bavaria, Germany

CRS Clinical-Research-Services Kiel GmbH Kiel, Schleswig-Holstein, Germany

View Trial Details

Completed

A Study to Learn How a Proton Pump Inhibitor Affects the Way Elinzanetant (BAY 3427080) Moves Into, Through and Out of the Body, and How Much of it Gets Absorbed by the Body When Taken as a Single and Small Radioactive Dose in Healthy Adults

NCT05061563

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine Gland Neoplasms, Endocrine System Diseases, +11 more
Locations: PRAHealthSciences Groningen, Netherlands

View Trial Details

Completed

Efficacy of Computerized Cognitive Training and Stimulant Medication in Neurofibromatosis Type 1

NCT02944032

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +14 more
Locations: Children's National Health System Washington D.C., District of Columbia, United States

View Trial Details

Completed

A Study to Learn What Happens to Elinzanetant in the Body When Taken With or Without Carbamazepine, and How Safe it is in Healthy Men and Women Aged 18 to 60 Years.

NCT05028608

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine Gland Neoplasms, Endocrine System Diseases, +8 more
Locations: CRS Clinical-Research-Services Mannheim GmbH Mannheim, Baden-Wurttemberg, Germany

View Trial Details

Completed

Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors

NCT02982941

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Desmoplastic Small Round Cell Tumor, Ewing Sarcoma, +33 more
Locations: Lucile Packard Children's Hospital, Stanford Palo Alto, California, United States

National Cancer Institute, Center for Cancer Research Bethesda, Maryland, United States

Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States

Texas Children's Hospital Houston, Texas, United States

View Trial Details

Completed

Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma

NCT02452554

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +45 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

Arkansas Children's Hospital Little Rock, Arkansas, United States

Kaiser Permanente Downey Medical Center Downey, California, United States

Loma Linda University Medical Center Loma Linda, California, United States

View all 69 locations

View Trial Details

Neoplastic Syndromes, Hereditary

Neoplastic Syndromes, Hereditary trial results

Related conditions